Skip to main content
Equibles

Adam Raymond Craig, M.D., Ph.D.

Board Member

X4 Pharmaceuticals, Inc (XFOR)

CEO

X4 Pharmaceuticals, Inc (XFOR)

Chairman

X4 Pharmaceuticals, Inc (XFOR)

Equibles does not estimate personal net worth.

Get an email with a short summary when X4 Pharmaceuticals, Inc publishes a filing, an earnings call transcript or a press release.

Get XFOR alerts

About Adam Raymond Craig, M.D., Ph.D.

Adam Raymond Craig, M.D., Ph.D. is recorded as Board Member, CEO and Chairman at X4 Pharmaceuticals, Inc (XFOR) since August 12, 2025. X4 Pharmaceuticals, Inc reported in an 8-K filed August 12, 2025 that Adam Raymond Craig, M.D., Ph.D. was appointed Class II director, effective August 12, 2025. X4 Pharmaceuticals, Inc reported in an 8-K filed August 12, 2025 that Adam Raymond Craig, M.D., Ph.D. was appointed Chairman of the Board, effective August 12, 2025. X4 Pharmaceuticals, Inc reported in an 8-K filed August 12, 2025 that Adam Raymond Craig, M.D., Ph.D. was appointed Executive Chairman and “principal executive officer”, effective August 12, 2025. X4 Pharmaceuticals, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at X4 Pharmaceuticals, Inc includes Michael Gray (CEO), Paula Ragan (CEO), Adam Craig (Chairman) and 7 others.

“On August 11, 2025, the Board also appointed Dr. Craig to serve on the Board as a Class II director, effective as of the Effective Time, until the Company’s annual meeting of stockholders in 2028 or his earlier death, resignation or removal.”
X4 Pharmaceuticals, Inc Form 8-K, filed August 12, 2025 · Read the filing
“the Board appointed Dr. Craig as the Chairman of the Board, in each case, effective as of the Effective Time.”
X4 Pharmaceuticals, Inc Form 8-K, filed August 12, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at X4 Pharmaceuticals, Inc

Recent activity